
Results
44
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
44 companies
CanSino Biologics
Market Cap: HK$9.6b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$23.18
7D
-2.5%
1Y
-48.3%
Akeso
Market Cap: HK$85.9b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$93.20
7D
-9.3%
1Y
-39.7%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €194.3m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.26
7D
-2.8%
1Y
6.7%
Innovent Biologics
Market Cap: HK$153.4b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$88.10
7D
-3.2%
1Y
-10.1%
Medexus Pharmaceuticals
Market Cap: CA$151.3m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$4.88
7D
-4.3%
1Y
78.1%
Aroa Biosurgery
Market Cap: AU$195.4m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.56
7D
-4.2%
1Y
-10.3%
InSilico Medicine Cayman TopCo
Market Cap: HK$24.1b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$42.06
7D
-13.2%
1Y
n/a
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.25
7D
2.0%
1Y
9.3%
AbbVie
Market Cap: US$465.2b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$257.41
7D
0.2%
1Y
36.2%
Teva Pharmaceutical Industries
Market Cap: US$40.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$35.41
7D
13.6%
1Y
129.2%
Idorsia
Market Cap: CHF 1.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 6.21
7D
2.1%
1Y
77.8%
AcrobiosystemsLtd
Market Cap: CN¥7.9b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥47.52
7D
-9.7%
1Y
-15.6%
Pangaea Oncology
Market Cap: €55.7m
A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.55
7D
0%
1Y
-9.9%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.5b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€51.50
7D
0.3%
1Y
2.2%
Merck
Market Cap: US$322.0b
Operates as a healthcare company worldwide.
MRK
US$129.79
7D
-0.5%
1Y
66.1%
AstraZeneca
Market Cap: UK£197.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£127.20
7D
0.3%
1Y
12.3%
Renata
Market Cap: ৳53.9b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
RENATA
৳470.20
7D
-0.8%
1Y
-8.0%
Chugai Pharmaceutical
Market Cap: JP¥11.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,071.00
7D
-2.0%
1Y
-3.9%
Mesoblast
Market Cap: AU$2.7b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.04
7D
-12.1%
1Y
-14.3%
Caliway Biopharmaceuticals
Market Cap: NT$160.3b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$104.00
7D
6.3%
1Y
-14.0%
WuXi XDC Cayman
Market Cap: HK$64.6b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$51.05
7D
-8.3%
1Y
-11.5%
Galderma Group
Market Cap: CHF 42.4b
Operates as a dermatology company worldwide.
GALD
CHF 180.65
7D
6.7%
1Y
41.7%
Travere Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$57.28
7D
-0.1%
1Y
266.5%
PharmaEssentia
Market Cap: NT$422.5b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,070.00
7D
-5.7%
1Y
165.3%
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.80
7D
-2.0%
1Y
17.6%
Sotera Health
Market Cap: US$5.0b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$17.85
7D
2.1%
1Y
55.4%
Selvita
Market Cap: zł487.3m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł26.55
7D
4.5%
1Y
-20.7%
Mesa Laboratories
Market Cap: US$557.7m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$101.04
7D
0.09%
1Y
32.1%
ALTEOGEN
Market Cap: ₩15.0t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩279,500.00
7D
-8.8%
1Y
-38.4%
SIGA Technologies
Market Cap: US$232.4m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$3.25
7D
4.5%
1Y
-49.7%
Ligand Pharmaceuticals
Market Cap: US$5.7b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$296.29
7D
-1.9%
1Y
125.2%
hVIVO
Market Cap: UK£53.2m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.077
7D
15.7%
1Y
-24.4%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.72
7D
3.7%
1Y
-27.0%
ALK-Abelló
Market Cap: DKK 50.3b
An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
ALK B
DKK 227.00
7D
-0.6%
1Y
18.7%
Sartorius Stedim Biotech
Market Cap: €16.6b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€170.10
7D
3.7%
1Y
-3.4%
Strides Pharma Science
Market Cap: ₹98.9b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹1,072.80
7D
4.0%
1Y
22.7%